Patents by Inventor Philip McDowell

Philip McDowell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • antigenic polypeptides and compositions
    Patent number: 8568731
    Abstract: The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising the polypeptides; recombinant methods to manufacture the polypeptides; and therapeutic antibodies directed to the polypeptides.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: October 29, 2013
    Assignee: Biosynexus Incorporated
    Inventors: Simon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke
  • Antigenic Polypeptides
    Publication number: 20100166792
    Abstract: The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising said polypeptides; recombinant methods to manufacture said polypeptides; and therapeutic antibodies directed to said polypeptides.
    Type: Application
    Filed: September 8, 2009
    Publication date: July 1, 2010
    Applicant: BIOSYNEXUS INCORPORATED
    Inventors: Simon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke
  • ANTIGENIC POLYPEPTIDES
    Publication number: 20090269349
    Abstract: The invention relates to a method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
    Type: Application
    Filed: August 11, 2008
    Publication date: October 29, 2009
    Applicants: UNIVERSITY OF SHEFFIELD, BIOSYNEXUS CORPORATION
    Inventors: Simon Foster, James Mond, Simon Clarke, Philip McDowell, Kirsty Brummel
  • Staphylococcus aureus antigenic polypeptides and compositions
    Patent number: 7585658
    Abstract: The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising such polypeptides; recombinant methods to manufacture such polypeptides; and therapeutic antibodies directed to such polypeptides.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: September 8, 2009
    Assignee: Biosynexus Incorporated
    Inventors: Simon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke
  • Antigenic polypeptides
    Patent number: 7410647
    Abstract: A method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: August 12, 2008
    Assignees: University of Sheffield, Biosynexus Incorporated
    Inventors: Simon Foster, James Mond, Simon Clarke, Philip McDowell, Kristy Brummel
  • Antigenic polypeptides
    Publication number: 20060140979
    Abstract: The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising said polypeptides; recombinant methods to manufacture said polypeptides; and therapeutic antibodies directed to said polypeptides.
    Type: Application
    Filed: October 24, 2005
    Publication date: June 29, 2006
    Inventors: Simon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke
  • Antigenic polypeptides
    Publication number: 20050256299
    Abstract: A method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
    Type: Application
    Filed: August 2, 2002
    Publication date: November 17, 2005
    Inventors: Simon Foster, James Mond, Simon Clarke, Philip McDowell, Kristy Brummel
  • Antigenic polypeptides
    Publication number: 20030186275
    Abstract: The invention relates to a method for the identification of antigenic polypeptides expressed by pathogenic microbes; vaccines comprising said polypeptides; recombinant methods to manufacutre said polypeptides; and therapeutic antibodies directed to said polypeptides.
    Type: Application
    Filed: March 18, 2003
    Publication date: October 2, 2003
    Inventors: Simon Foster, Philip McDowell, Kirsty Brummell, Simon Clarke